(Q37792984)

23 August 2017

1 reference

30 June 2021

Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design (English)

1 reference

23 August 2017

0 references

1 reference

1 reference

1 reference

30 June 2021

Marianne Manchester

2

0 references

Emily Plummer

series ordinal

1

object named as

Emily M Plummer

1 reference

23 August 2017

24 September 2010

2 references

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

23 August 2017

30 June 2021

2 references

23 August 2017

30 June 2021

3

1 reference

23 August 2017

2

1 reference

23 August 2017

174-196

1 reference

Prevention of cancer through immunization: Prospects and challenges for the 21st century.

23 August 2017

1 reference

A vaccine against nicotine for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

Bacterial strategies for overcoming host innate and adaptive immune responses

21 January 2018

1 reference

Positive and negative selection of T cells

21 January 2018

1 reference

Persistence of memory CD8 T cells in MHC class I-deficient mice

21 January 2018

1 reference

Improving vaccine performance with adjuvants

21 January 2018

1 reference

The Jenner bicentenary: the introduction and early distribution of smallpox vaccine

21 January 2018

1 reference

Viremia, invasiveness, and the influence of injections.

21 January 2018

1 reference

Hepatitis A virus: from discovery to vaccines

21 January 2018

1 reference

Subunit interactions in bovine papillomavirus

21 January 2018

1 reference

Atomic model of the papillomavirus capsid

21 January 2018

1 reference

High-resolution Electron Microscopy of Helical Specimens: A Fresh Look at Tobacco Mosaic Virus

21 January 2018

1 reference

VIPERdb2: an enhanced and web API enabled relational database for structural virology

21 January 2018

1 reference

Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells

21 January 2018

1 reference

Virus-like particles as immunogens

21 January 2018

1 reference

Virus-like particles-universal molecular toolboxes

21 January 2018

1 reference

Nanotechnology in vaccine delivery

21 January 2018

1 reference

Human hepatitis B vaccine from recombinant yeast

21 January 2018

1 reference

Antibody responses to preS components after immunization of children with low doses of BioHepB.

21 January 2018

1 reference

Oral immunization with hepatitis B surface antigen expressed in transgenic plants

21 January 2018

1 reference

Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females

21 January 2018

1 reference

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

21 January 2018

1 reference

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral

21 January 2018

1 reference

Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.

21 January 2018

1 reference

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

21 January 2018

1 reference

Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection

21 January 2018

1 reference

Case-control study of human papillomavirus and oropharyngeal cancer

21 January 2018

1 reference

Virus-sized vaccine delivery systems

21 January 2018

1 reference

Recombinant vaccines for hepatitis E.

21 January 2018

1 reference

Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus

21 January 2018

1 reference

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers

21 January 2018

1 reference

Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice

21 January 2018

1 reference

Virus-like particles production in green plants

21 January 2018

1 reference

Induction of a protective immune response against viral nervous necrosis in the European sea bass Dicentrarchus labrax by using betanodavirus virus-like particles

21 January 2018

1 reference

Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.

21 January 2018

1 reference

Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins

21 January 2018

1 reference

Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge

21 January 2018

1 reference

Virus-like particles as HIV-1 vaccines

21 January 2018

1 reference

GP120: target for neutralizing HIV-1 antibodies

21 January 2018

1 reference

Virus-like particles: passport to immune recognition

21 January 2018

1 reference

Progress towards the development of a HIV-1 gp41-directed vaccine

21 January 2018

1 reference

Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates

21 January 2018

1 reference

Hepatitis C virus-like particles induce virus-specific humoral and cellular immune responses in mice

21 January 2018

1 reference

Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection

21 January 2018

1 reference

Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections

21 January 2018

1 reference

Ebola virus-like particles protect from lethal Ebola virus infection

21 January 2018

1 reference

Filovirus-like particles as vaccines and discovery tools

21 January 2018

1 reference

Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system.

21 January 2018

1 reference

A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection

21 January 2018

1 reference

Translating innate response into long-lasting antibody response by the intrinsic antigen-adjuvant properties of papaya mosaic virus.

21 January 2018

1 reference

Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation

21 January 2018

1 reference

A viral nanoparticle with dual function as an anthrax antitoxin and vaccine

21 January 2018

1 reference

A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity

21 January 2018

1 reference

Cryo-electron microscopy study of bacteriophage T4 displaying anthrax toxin proteins

21 January 2018

1 reference

Native display of complete foreign protein domains on the surface of hepatitis B virus capsids.

21 January 2018

1 reference

Immunogenicity of peptide fusions to hepatitis B virus core antigen

21 January 2018

1 reference

Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus.

21 January 2018

1 reference

A universal influenza A vaccine based on the extracellular domain of the M2 protein

21 January 2018

1 reference

Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein

21 January 2018

1 reference

Presentation and Immunogenicity of Viral Epitopes on the Surface of Hybrid Hepatitis B Virus Core Particles Produced in Bacteria

21 January 2018

1 reference

Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles

21 January 2018

1 reference

A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts

21 January 2018

1 reference

Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes.

21 January 2018

1 reference

Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques

21 January 2018

1 reference

Insertion of a foreign sequence on capsid surface loops of human papillomavirus type 16 virus-like particles reduces their capacity to induce neutralizing antibodies and delineates a conformational neutralizing epitope

21 January 2018

1 reference

Cowpea mosaic virus-based systems for the production of antigens and antibodies in plants

21 January 2018

1 reference

Structure-based design of peptide presentation on a viral surface: the crystal structure of a plant/animal virus chimera at 2.8 A resolution

21 January 2018

1 reference

Interaction of Cowpea mosaic virus (CPMV) nanoparticles with antigen presenting cells in vitro and in vivo

21 January 2018

1 reference

Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus

21 January 2018

1 reference

Characterization of the immune response to canine parvovirus induced by vaccination with chimaeric plant viruses.

21 January 2018

1 reference

Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus

21 January 2018

1 reference

Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus

21 January 2018

1 reference

A chimaeric plant virus vaccine protects mice against a bacterial infection

21 January 2018

1 reference

Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus

21 January 2018

1 reference

Efficient generation of cowpea mosaic virus empty virus-like particles by the proteolytic processing of precursors in insect cells and plants

21 January 2018

1 reference

Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope

21 January 2018

1 reference

Expression of foot-and-mouth disease virus epitopes in tobacco by a tobacco mosaic virus-based vector*1

21 January 2018

1 reference

A modified TMV-based vector facilitates the expression of longer foreign epitopes in tobacco

21 January 2018

1 reference

Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P. aeruginosa

21 January 2018

1 reference

Cucumber mosaic virus as a presentation system for a double hepatitis C virus-derived epitope.

21 January 2018

1 reference

Immunogenic properties of a chimeric plant virus expressing a hepatitis C virus (HCV)-derived epitope: new prospects for an HCV vaccine

21 January 2018

1 reference

Peptide-based candidate vaccine against respiratory syncytial virus

21 January 2018

1 reference

Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses.

21 January 2018

1 reference

Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.

21 January 2018

1 reference

MS2 coat protein mutants which bind Qbeta RNA.

21 January 2018

1 reference

Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2

21 January 2018

1 reference

Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis

21 January 2018

1 reference

Protective immunity induced by phage displayed mitochondrial related peptides of Schistosoma japonicum

21 January 2018

1 reference

Versatile virus-like particle carrier for epitope based vaccines

21 January 2018

1 reference

Multicomponent anthrax toxin display and delivery using bacteriophage T4.

21 January 2018

1 reference

In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc-capsid interactions: a strategy for efficient display of large full-length proteins

21 January 2018

1 reference

Expression and immunoreactivity of an epitope of HCV in a foreign epitope presenting system

21 January 2018

1 reference

Expression and immunoreactivity of HCV/HBV epitopes

21 January 2018

1 reference

Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system

21 January 2018

1 reference

A new epitope presenting system displays a HIV-1 V3 loop sequence and induces neutralizing antibodies.

21 January 2018

1 reference

Recent insights into the biology and biomedical applications of Flock House virus

21 January 2018

1 reference

Expression and purification of Dengue virus type 2 envelope protein as a fusion with hepatitis B surface antigen in Pichia pastoris

21 January 2018

1 reference

Recombinant dengue virus type 2 envelope/hepatitis B surface antigen hybrid protein expressed in Pichia pastoris can function as a bivalent immunogen.

21 January 2018

1 reference

Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein

21 January 2018

1 reference

Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein--a preliminary study on immunogenicity

21 January 2018

1 reference

A controlled trial of a human papillomavirus type 16 vaccine

21 January 2018

1 reference

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

21 January 2018

1 reference

Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice

21 January 2018

1 reference

Triple layered rotavirus VLP production: kinetics of vector replication, mRNA stability and recombinant protein production.

21 January 2018

1 reference

Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses

21 January 2018

1 reference

HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae

21 January 2018

1 reference

Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy

21 January 2018

1 reference

Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the hepatitis B core antigen (HBcAg) c/e1-region.

21 January 2018

1 reference

Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes

21 January 2018

1 reference

Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults

21 January 2018

1 reference

Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine

21 January 2018

1 reference

Theileria annulata sporozoite antigen fused to hepatitis B core antigen used in a vaccination trial

21 January 2018

1 reference

Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and [...]

21 January 2018

1 reference

Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine

21 January 2018

1 reference

Generating neutralizing antibodies, Th1 response and MHC non restricted immunogenicity of HIV-I env and gag peptides in liposomes and ISCOMs with in-built adjuvanticity

21 January 2018

1 reference

The utility of ISCOMATRIX adjuvant for dose reduction of antigen for vaccines requiring antibody responses.

21 January 2018

1 reference

Single epitope mucosal vaccine delivered via immuno-stimulating complexes induces low level of immunity against simian-HIV.

21 January 2018

1 reference

The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses

21 January 2018

1 reference

Systemic and intestinal antibody secreting cell responses and protection in gnotobiotic pigs immunized orally with attenuated Wa human rotavirus and Wa 2/6-rotavirus-like-particles associated with immunostimulating complexes

21 January 2018

1 reference

Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigens

21 January 2018

1 reference

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A

21 January 2018

1 reference

A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks

21 January 2018

1 reference

Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy

21 January 2018

1 reference

Phase 1 clinical tests of influenza MDP-virosome vaccine (KD-5382).

21 January 2018

1 reference

Novel adjuvant strategies for experimental malaria and AIDS vaccines

21 January 2018

1 reference

Evaluation of genetic immunization adjuvants to improve the effectiveness of a human immunodeficiency virus type 2 (HIV-2) envelope DNA vaccine

21 January 2018

1 reference

Oral particulate delivery: status and future trends

21 January 2018

1 reference

Stimulating role of toxoids-laden liposomes in oral immunization against diphtheria and tetanus infections

21 January 2018

1 reference

IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization

21 January 2018

1 reference

Parameters affecting the immunogenicity of microencapsulated tetanus toxoid

21 January 2018

1 reference

Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro

21 January 2018

1 reference

Comparison of the immunological and protective responses elicited by microencapsulated formulations of the F1 antigen from Yersinia pestis

21 January 2018

1 reference

Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion.

21 January 2018

1 reference

Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge

21 January 2018

1 reference

Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type 1 isolates

21 January 2018

1 reference

A novel, killed-virus nasal vaccinia virus vaccine

21 January 2018

1 reference

Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine

21 January 2018

1 reference

Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles

21 January 2018

1 reference

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

21 January 2018

1 reference

Virosomal adjuvanted antigen delivery systems

21 January 2018

1 reference

Cholera toxin induces migration of dendritic cells from the subepithelial dome region to T- and B-cell areas of Peyer's patches

21 January 2018

1 reference

21 January 2018

1 reference

Virus-like particles as a vaccine delivery system: myths and facts.

21 January 2018

1 reference

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

21 January 2018

1 reference

Bacteriophage T4 capsid: a unique platform for efficient surface assembly of macromolecular complexes

21 January 2018

1 reference

The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity

21 January 2018

1 reference

12 December 2020

Oral immunization with Helicobacter pylori-loaded poly(D, L-lactide-co-glycolide) nanoparticles

1 reference

12 December 2020

Plant-derived vaccine protects target animals against a viral disease

1 reference

12 December 2020

A comparison of oral and parenteral routes for therapeutic vaccination with HSV-2 ISCOMs in mice; cytokine profiles, antibody responses and protection

1 reference

12 December 2020

Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells

1 reference

12 December 2020

Expression of a human cytomegalovirus gp58 antigenic domain fused to the hepatitis B virus nucleocapsid protein

1 reference

12 December 2020

Toll-like receptors and their ligands.

1 reference

12 December 2020

Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine

1 reference

12 December 2020

Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine

1 reference

12 December 2020

Expression of hepatitis B virus core antigen gene in Saccharomyces cerevisiae: synthesis of two polypeptides translated from different initiation codons

1 reference

12 December 2020

Protection against hepatitis A by an inactivated vaccine

1 reference

12 December 2020

Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres

1 reference

12 December 2020

Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses

1 reference

12 December 2020

Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytes

1 reference

12 December 2020

Selective binding and transcytosis of latex microspheres by rabbit intestinal M cells

1 reference

12 December 2020

Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology

1 reference

12 December 2020

Hepatitis C virus structural proteins assemble into viruslike particles in insect cells

1 reference

12 December 2020

Inflexal V a trivalent virosome subunit influenza vaccine: production

1 reference

12 December 2020

Emerging Concept of Poliomyelitis Infection

1 reference

12 December 2020

Influence of three-dimensional structure on the immunogenicity of a peptide expressed on the surface of a plant virus

1 reference

12 December 2020

[Cloning, sequencing, expression, and primary identification of recombinant mouse protein kinase CK2 alpha subunit]

1 reference

12 December 2020

Evaluation of recombinant sporozoite antigen SPAG-1 as a vaccine candidate against Theileria annulata by the use of different delivery systems

1 reference

12 December 2020

Antibodies against a truncated Staphylococcus aureus fibronectin-binding protein protect against dissemination of infection in the rat

1 reference

12 December 2020

The Jenner bicentenary: the introduction and early distribution of smallpox vaccine

1 reference

12 December 2020

Comparison of poly(DL-lactide-co-glycolide) and polystyrene microsphere targeting to intestinal M cells

1 reference

12 December 2020

Identification and characterization of a protective immunodominant B cell epitope of pertactin (P.69) fromBordetella pertussis

1 reference

12 December 2020

Effect of oral rotavirus/iscom vaccines on immune responses in gnotobiotic lambs

1 reference

12 December 2020

The GAG precursor of simian immunodeficiency virus assembles into virus-like particles

1 reference

12 December 2020

Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.

1 reference

12 December 2020

Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines

1 reference

12 December 2020

Expression and self-assembly of empty virus-like particles of hepatitis E virus

1 reference

12 December 2020

HIV-1 epitopes exposed by hybrid hepatitis B core particles affect proliferation of peripheral blood mononuclear cells from HIV-1 positive donors

1 reference

12 December 2020

RNA Bacteriophage Capsid-Mediated Drug Delivery and Epitope Presentation

1 reference

12 December 2020

Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine

1 reference

12 December 2020

A new pre-S containing recombinant hepatitis B vaccine and its effect on non-responders: a preliminary observation

1 reference

12 December 2020

Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins

1 reference

12 December 2020

Evaluation of biodegradable microspheres as vaccine adjuvant for hepatitis B surface antigen

1 reference

12 December 2020

Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.

1 reference

12 December 2020

Improved reactivity of hepatitis C virus core protein epitopes in a conformational antigen-presenting system

1 reference

12 December 2020

Identifiers

DOI

10.1002/WNAN.119

1 reference

23 August 2017

0 references

1 reference

PubMed ID

20872839